Respironics, headquartered in Murrysville, Pennsylvania, USA, develops, manufactures and markets medical devices used mainly in the treatment of patients suffering from respiratory disorders. The company's principal product lines are continuous positive airway pressure (CPAP) devices and bi-level positive airway pressure devices used in the home for the treatment of obstructive sleep apnoea (OSA); respiratory devices, including bi-level non-invasive ventilatory support units, critical care units that can deliver both non-invasive and invasive ventilation; non-invasive cardiorespiratory monitors; portable invasive volume ventilator units used in the home; home oxygen devices, diagnostic and monitoring systems, developmental care products used for premature infants; and asthma and allergy devices for both home and hospital use.
Read entire article